What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients’ Quality of Life?

Walker, 2013, Incidence of venous thromboembolism in patients with cancer—a cohort study using linked United Kingdom databases, Eur J Cancer, 49, 1404, 10.1016/j.ejca.2012.10.021 Prandoni, 2002, Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis, Blood, 100, 3484, 10.1182/blood-2002-01-0108 Hutten, 2000, Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis, J Clin Oncol, 18, 3078, 10.1200/JCO.2000.18.17.3078 Farge, 2013, International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, J Thromb Haemost, 11, 56, 10.1111/jth.12070 Lyman, 2013, Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update, J Clin Oncol, 31, 2189, 10.1200/JCO.2013.49.1118 Wittkowsky, 2006, Barriers to the long-term use of low-molecular weight heparins for treatment of cancer-associated thrombosis, J Thromb Haemost, 4, 2090, 10.1111/j.1538-7836.2006.02073.x Khorana, 2016, Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?, Thromb Res, 145, 51, 10.1016/j.thromres.2016.07.013 Seaman, 2014, Cancer-associated thrombosis, low-molecular-weight heparin, and the patient experience: a qualitative study, Patient Prefer Adherence, 8, 453 Noble, 2015, Assessing patients’ anticoagulation preferences for the treatment of cancer-associated thrombosis using conjoint methodology, Haematologica, 100, 1486, 10.3324/haematol.2015.127126 Lee, 2014, A randomized trial of long-term tinzaparin, a low molecular weight heparin (LMWH), versus warfarin for treatment of acute venous thromboembolism (VTE) in cancer patients—the CATCH study, Blood, 284 2013 Dolan, 1997, Modeling valuations for EuroQol health states, Med Care, 35, 1095, 10.1097/00005650-199711000-00002 Vazquez, 2010, Postthrombotic syndrome, Circulation, 121, e217, 10.1161/CIRCULATIONAHA.109.925651 Fairclough, 2002 Verbeke, 2000 Diggle, 2002 König, 2009, Comparison of population health status in six European countries: results of a representative survey using the EQ-5D questionnaire, Med Care, 47, 255, 10.1097/MLR.0b013e318184759e Szende, 2014 Kahn, 2008, Determinants of health-related quality of life during the 2 years following deep vein thrombosis, J Thromb Haemost, 6, 1105, 10.1111/j.1538-7836.2008.03002.x